CVE-2020-27266
lowpriority · track · 26EPSS 0.006 · 47 %ileEUUSEPSS · scored 2026-10-24
In SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-A, a client-side control vulnerability in the insulin pump and its AnyDana-i and AnyDana-A mobile applications allows physically proximate attackers to bypass user authentication checks via Bluetooth Low Energy.
remediations
Vendor fix, mitigation, or workaround guidance, as published by each source.
A vendor fix is available.
- FixedAnyDana-Acisa_csaf_ot
Dana Diabecare recommends users update the Dana Diabecare insulin pumps to Version 3.0 or higher, or to the latest available release. Additionally, users are encouraged to immediately update AnyDana-A and AnyDana-i to Version 3.0 or higher. Also, SOOIL recommends users to apply these mitigating strategies:
- FixedAnyDana-icisa_csaf_ot
Dana Diabecare recommends users update the Dana Diabecare insulin pumps to Version 3.0 or higher, or to the latest available release. Additionally, users are encouraged to immediately update AnyDana-A and AnyDana-i to Version 3.0 or higher. Also, SOOIL recommends users to apply these mitigating strategies:
- FixedDana Diabecare RScisa_csaf_ot
Dana Diabecare recommends users update the Dana Diabecare insulin pumps to Version 3.0 or higher, or to the latest available release. Additionally, users are encouraged to immediately update AnyDana-A and AnyDana-i to Version 3.0 or higher. Also, SOOIL recommends users to apply these mitigating strategies:
cvss
Technical severity, 0–10. One row per scoring source.
base score 0–10 · higher = more severe · hover a vector to decode⚠ sources disagree · low–medium · 3.3–6.5
weaknesses
The CWE weakness classes this flaw belongs to.
affected products (10)
Products and version ranges known to be affected.
- n/a SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-A≤ Dana Diabecare RS, AnyDana-i, AnyDana-A All versions prior to 3.0enisa_euvdEU
advisories (1)
Vendor and ecosystem advisories describing this.
- ICSMA-21-012-01SOOIL Dana Diabecare RS Products2021-01-12icsa · cisa_csaf_otUS
Successful exploitation of these vulnerabilities could allow an attacker to access sensitive information, modify therapy settings, bypass authentication, or crash the device being accessed. These vulnerabilities could affect patient safety.
also known as (3)
Other names and identifiers for this entity.
sources
Which sources assert this record, and when.
references (5)
External citations — patches, advisories, analysis.
- http://www.sooil.com/eng/Patchcnnvd
- https://us-cert.cisa.gov/ics/advisories/icsma-21-012-01cnnvd
- https://www.auscert.org.au/bulletins/ESB-2021.0122/cnnvd
- https://us-cert.cisa.gov/ics/advisories/icsma-21-012-01enisa_euvd
- https://us-cert.cisa.gov/ics/advisories/icsma-21-012-01Third Party AdvisoryUS Government Resourcenvd
Attackers weaponise vulnerabilities like this against internet-exposed services. See what is exposed on your perimeter with a free passive scan.
Free scan